Soma Pharmacy Blognews

FDA Warns Illegal Codeine Makers
WASHINGTON (MedPage Today) — The FDA issued a strict warning to four drug manufacturers today: stop making unapproved and illegal codeine sulfate tablets.

Workout Fights Chemo Fatigue
Cancer patients find chemotherapy less physically and emotionally exhausting if they’re in an intense program of cardio, strength, relaxation, and body-awareness training.

Less Invasive Surgery Repairs Aortic Aneurysm
Less invasive endoscopic repair of deadly aortic aneurysms is easier on patients and — at least for 2 years — carries no extra risk of death.

Too Many Mastectomies? Maybe Not
Doctors recommend breast-conserving surgery for 3 in 4 women with early breast cancer. Second opinions rarely differ, so surgeon advice doesn’t raise mastectomy rates.

Robot Prostate Surgery: More ED, Incontinence
Minimally invasive prostate surgery — often performed using a high-tech robot — carries a higher risk of incontinence and erectile dysfunction than does open surgery.

Hip Fractures on the Decline in U.S.
Hip fracture rates and deaths related to such injuries are decreasing in the U.S. among people aged 65 and older, a study shows.

MSDC To Test Potential Treatment For Alzheimer’s
Grant from the Alzheimer’s Drug Discovery Foundation to support research

Meda Pharmaceuticals introduces Onsolis for treating breakthrough cancer pain
Meda Pharmaceuticals Inc. today announced the launch of Onsolis(TM)(fentanyl buccal soluble film) in the U.S. for the management of breakthrough pain (BTP) in patients with cancer, eighteen years of age and older, who are already receiving and who are tolerant to opioid therapy for their underlying persistent [...]

Researchers to investigate existing drug for speedier recovery of stroke patients
New research will determine whether an inexpensive drug called L-dopa, widely used in the treatment of Parkinson’s disease, could also help thousands of stroke patients regain mobility and independence.

Sequella receives Phase 1 SBIR grant for developing SQ641
Sequella, Inc., a clinical-stage biopharmaceutical company focused on commercializing novel antibiotics to treat life-threatening infectious diseases, today announced that it received a $594,661 two-year Small Business Innovative Research (SBIR) grant from the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) for the [...]